Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
144.5 DKK | +0.56% | -5.31% | +42.79% |
Jun. 04 | Transcript : ALK-Abelló A/S - Analyst/Investor Day | |
Jun. 03 | ALK Presents Positive Phase 3 Paediatric Trial Data Offering New Hope for Children with Respiratory Allergy | CI |
Sales 2024 * | 5.39B 778M | Sales 2025 * | 6.01B 867M | Capitalization | 31.78B 4.58B |
---|---|---|---|---|---|
Net income 2024 * | 771M 111M | Net income 2025 * | 1.13B 163M | EV / Sales 2024 * | 5.85 x |
Net cash position 2024 * | 248M 35.79M | Net cash position 2025 * | 1.01B 146M | EV / Sales 2025 * | 5.12 x |
P/E ratio 2024 * |
40.2
x | P/E ratio 2025 * |
28.1
x | Employees | 2,828 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.05% |
Latest transcript on ALK-Abelló A/S
1 day | +1.11% | ||
1 week | -5.83% | ||
Current month | -5.83% | ||
1 month | -6.26% | ||
3 months | +8.95% | ||
6 months | +54.27% | ||
Current year | +42.00% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Halling
CEO | Chief Executive Officer | 47 | Dec. 31 |
Director of Finance/CFO | 52 | 23-05-31 | |
Chief Tech/Sci/R&D Officer | - | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 21-03-17 | |
Anders Hedegaard
CHM | Chairman | 63 | 20-03-10 |
Director/Board Member | 64 | 15-03-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.03% | 775 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 144.5 | +0.56% | 207 431 |
24-06-07 | 143.7 | +1.55% | 296,538 |
24-06-06 | 141.5 | -0.07% | 425,353 |
24-06-04 | 141.6 | -7.39% | 1,309,994 |
24-06-03 | 152.9 | +0.20% | 391,832 |
Delayed Quote Nasdaq Copenhagen, June 07, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.00% | 4.6B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- ALK B Stock